86 related articles for article (PubMed ID: 8894971)
1. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA.
Swart PJ; Beljaars E; Smit C; Pasma A; Schuitemaker H; Meijer DK
J Drug Target; 1996; 4(2):109-16. PubMed ID: 8894971
[TBL] [Abstract][Full Text] [Related]
2. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT.
Kuipers ME; Swart PJ; Witvrouw M; Esté JA; Reymen D; De Clercq E; Meijer DK
J Drug Target; 1999; 6(5):323-35. PubMed ID: 10342381
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic analysis and cellular distribution of the anti-HIV compound succinylated human serum albumin (Suc-HSA) in vivo and in the isolated perfused rat liver.
Jansen RW; Olinga P; Harms G; Meijer DK
Pharm Res; 1993 Nov; 10(11):1611-4. PubMed ID: 8290473
[TBL] [Abstract][Full Text] [Related]
5. The metabolic fate of the Anti-HIV active drug carrier succinylated human serum albumin after intravenous administration in rats.
Swart PJ; Kuipers ME; Smit C; Beljaars L; Ter Wiel J; Meijer DK
J Drug Target; 2001 Apr; 9(2):95-109. PubMed ID: 11697111
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity.
Kamps JA; Swart PJ; Morselt HW; Pauwels R; De Béthune MP; De Clercq E; Meijer DK; Scherphof GL
Biochim Biophys Acta; 1996 Jan; 1278(2):183-90. PubMed ID: 8593275
[TBL] [Abstract][Full Text] [Related]
7. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
Cabrera C; Witvrouw M; Gutiérrez A; Clotet B; Kuipers ME; Swart PJ; Meijer DK; Desmyter J; De Clercq E; Esté JA
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1535-43. PubMed ID: 10580404
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice.
Kuipers ME; Swart PJ; Schutten M; Smit C; Proost JH; Osterhaus AD; Meijer DK
Antiviral Res; 1997 Jan; 33(2):99-108. PubMed ID: 9021051
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Succinylated Serum Albumin in Wistar Rats and Cynomolgus Monkeys: Implications for Dosage Regimens in the Therapy of HIV Infection.
Swart PJ; Schutten M; Smit C; van Amerongen G; Proost JH; Osterhaus AD; Meijer DK
Drug Deliv; 1996; 3(3):165-71. PubMed ID: 26790912
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the pharmacokinetics of succinylated human serum albumin in man from in vivo disposition data in animals and in vitro liver slice incubations.
Proost JH; Beljaars L; Olinga P; Swart PJ; Kuipers ME; Reker-Smit C; Groothuis GM; Meijer DK
Eur J Pharm Sci; 2006 Feb; 27(2-3):123-32. PubMed ID: 16219448
[TBL] [Abstract][Full Text] [Related]
11. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins.
Beljaars L; Floris R; Berkhout B; Smit C; Meijer DK; Molema G
Biochem Pharmacol; 2002 May; 63(9):1663-73. PubMed ID: 12007569
[TBL] [Abstract][Full Text] [Related]
12. Homing of negatively charged albumins to the lymphatic system: general implications for drug targeting to peripheral tissues and viral reservoirs.
Swart PJ; Beljaars L; Kuipers ME; Smit C; Nieuwenhuis P; Meijer DK
Biochem Pharmacol; 1999 Nov; 58(9):1425-35. PubMed ID: 10513986
[TBL] [Abstract][Full Text] [Related]
13. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
[TBL] [Abstract][Full Text] [Related]
14. Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes.
Jansen RW; Kruijt JK; van Berkel TJ; Meijer DK
Hepatology; 1993 Jul; 18(1):146-52. PubMed ID: 7686877
[TBL] [Abstract][Full Text] [Related]
15. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.
Kamps JA; Morselt HW; Swart PJ; Meijer DK; Scherphof GL
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11681-5. PubMed ID: 9326670
[TBL] [Abstract][Full Text] [Related]
16. Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: the influence of charge density and size of the proteins molecules.
Yamasaki Y; Hisazumi J; Yamaoka K; Takakura Y
Eur J Pharm Sci; 2003 Apr; 18(5):305-12. PubMed ID: 12694882
[TBL] [Abstract][Full Text] [Related]
17. Charge modification of plasma and milk proteins results in antiviral active compounds.
Swart PJ; Harmsen MC; Kuipers ME; Van Dijk AA; Van Der Strate BW; Van Berkel PH; Nuijens JH; Smit C; Witvrouw M; De Clercq E; de Béthune MP; Pauwels R; Meijer DK
J Pept Sci; 1999 Dec; 5(12):563-76. PubMed ID: 10628656
[TBL] [Abstract][Full Text] [Related]
18. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules.
Franssen EJ; Jansen RW; Vaalburg M; Meijer DK
Biochem Pharmacol; 1993 Mar; 45(6):1215-26. PubMed ID: 8466542
[TBL] [Abstract][Full Text] [Related]
19. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
20. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
